Tci Wealth Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

$1.12 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$23.68 - $38.51 $10,253 - $16,674	433 Added 25.56%	2,127 $54,000
Q4 2022 Feb 06, 2023	SELL	$28.0 - $40.56 $4,732 - $6,854	-169 Reduced 9.07%	1,694 $68,000
Q2 2022 Jul 19, 2022	SELL	$27.79 - $50.61 $9,670 - $17,612	-348 Reduced 15.74%	1,863 $66,000
Q1 2022 Apr 29, 2022	BUY	$39.62 - $69.97 $911 - $1,609	23 Added 1.05%	2,211 $102,000
Q4 2021 Jan 24, 2022	BUY	$58.09 - $82.51 $2,149 - $3,052	37 Added 1.72%	2,188 $145,000
Q3 2021 Oct 29, 2021	SELL	$58.38 - $84.96 $33,918 - $49,361	-581 Reduced 21.27%	2,151 $134,000
Q2 2021 Aug 02, 2021	SELL	$62.15 - $90.32 $683 - $993	-11 Reduced 0.4%	2,732 $226,000
Q1 2021 Apr 29, 2021	SELL	$61.35 - $90.47 $306 - $452	-5 Reduced 0.18%	2,743 $182,000
Q3 2020 Oct 20, 2020	SELL	$33.21 - $51.27 $4,549 - $7,023	-137 Reduced 4.75%	2,748 $118,000
Q1 2020 Apr 14, 2020	SELL	$20.56 - $63.12 $47,740 - $146,564	-2,322 Reduced 44.59%	2,885 $83,000
Q4 2019 Jan 27, 2020	BUY	$28.14 - $73.01 $253 - $657	9 Added 0.17%	5,207 $330,000
Q3 2019 Oct 17, 2019	SELL	$26.26 - $34.86 $2,626 - $3,486	-100 Reduced 1.89%	5,198 $146,000
Q2 2019 Jul 23, 2019	BUY	$17.43 - $28.82 $86,940 - $143,754	4,988 Added 1609.03%	5,298 $140,000
Q1 2019 Apr 11, 2019	SELL	$12.05 - $20.18 $1,205 - $2,018	-100 Reduced 24.39%	310 $6,000
Q4 2018 Jan 17, 2019	BUY	$10.74 - $19.7 $3,222 - $5,910	300 Added 272.73%	410 $5,000
Q2 2018 Jul 27, 2018	BUY	$6.37 - $14.02 $637 - $1,402	100 Added 1000.0%	110 $1,000
Q4 2017 Feb 01, 2018	BUY	$3.14 - $4.5 $31 - $45	10 New	10 $0
Q3 2017 Oct 24, 2017	SELL	$1.69 - $4.33 $169 - $433	-100 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	100	100 $0

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.

Account